The National Institutes of Health has persuaded 10 rival drugmakers to briefly set aside their competitive spirits and collaborate on drug discovery projects in four major diseases, pooling their data and expertise to kick-start early-stage efforts. Under the 5-year plan, the drugmakers will contribute some of their brightest minds in Alzheimer’s, Type 2 diabetes, rheumatoid […]
↧